BDBM419167 4-(((1R,5S,6R)-3- oxabicyclo[3.1.0]hexan-6- yl)methoxy)-N-(4- ethylphenyl)-N-isobutyl-3- (S- methylsulfonimidoyl)benzene- sulfonamide::US10457637, Compound 35

SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(OC[C@H]2[C@@H]3COC[C@H]23)c(c1)S(C)(=N)=O

InChI Key InChIKey=OAQZONMWSJLSBQ-OSFIVMRTSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 419167   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM419167(4-(((1R,5S,6R)-3- oxabicyclo[3.1.0]hexan-6- yl)met...)
Affinity DataIC50: <100nMAssay Description:The RORγ transactivation model was developed from the line HG5LN, which is a HeLa line that stably expresses a luciferase reporter gene controll...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent